hero

Leverage our network to build your career.

MR
Monte Rosa Therapeutics
monterosatx.com

Locations

Boston, MA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series C+

founded in

2018

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.

Something looks off?
Open jobs at Monte Rosa Therapeutics

On-site & Remote